NCR Tables - Distribution By Histopathology Findings

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
N04BD02	RAZYLECT 0.5	G	Rasagiline mesylate - 0.5mg	0.5mg	Tablet	2,036,369 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
L04AD02	PROGRAF 0.5 MG	B	Tacrolimus - 0.5mg	0.5mg	Capsule	L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	943,377 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	942,034 L.L
J01DD04	MEGION-A	G	Ceftriaxone - 0.5g/2ml, Lidocaine (ampoule) -	0.5g/2ml	Injectable powder + solvent	342,285 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01XA01	VANCOLON	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable lyophilised powder for solution	1,009,226 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	433,869 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	840,861 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	5,875,791 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DH02	AROPEM	G	Meropenem (trihydrate) - 0.5g	0.5g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	19,022,727 L.L
M02AA07	PIROXICALM	G	Piroxicam - 0.5%	0.5%	Gel	207,336 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 0.5%	0.5%	Injectable solution	1,441,943 L.L
S02DC	WAXSOL	B	Docusate sodium - 0.5%	0.5%	Drops solution	157,230 L.L
P01AB01	METRIS	G	Metronidazole - 500mg/100ml	0.5%	Injectable solution	142,447 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 0.5%	0.5%	Injectable solution	1,995,158 L.L
S01AE07	AROX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	423,310 L.L
S01AE07	FORTYMOX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops solution	772,709 L.L
S01AE07	IMOX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	464,970 L.L

جداول بيانية لسجل الوطني للسرطان - توزيع الحالات حسب خصائص الانسجة